Genetically Modified Stem Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Genetically Modified Stem Cells, covering 2014-06-02 to 2014-06-02. Get the full timeline:
Most recent: Clinical Trial Update: Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas [Phase 1]